Cells
Cure8 research brief
Why This Matters
The review links macrophage-driven repair mechanisms to chronic inflammation and fibrosis in autoimmune diseases, including IBD, and highlights experimental strategies that aim to promote resolution rather than suppress inflammation. This could point toward future therapies that reduce tissue damage in IBD.
Who Should Pay Attention
Clinicians; researchers in IBD, immunology, and tissue repair; investigators focused on therapeutic development
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This is a scientific review focusing on macrophage plasticity, efferocytosis, metabolic rewiring, and macrophage–fibroblast crosstalk in tissue repair and maladaptive fibrosis.
The authors summarize evidence linking dysregulated repair circuits to autoimmune conditions (RA, SSc, and IBD) and discuss emerging “resolution therapies” such as specialized pro-resolving mediators and macrophage reprogramming approaches.
The paper is an abstract-based review (source-provided abstract) and synthesizes recent basic and translational studies rather than reporting a single new clinical trial or patient-level data. It may be most useful for clinicians and researchers interested in immune mechanisms and therapeutic development rather than immediate changes to patient care.
Keep In Mind
Source is a peer-reviewed journal review (Cells) and the provided content is abstract-level synthesis. The article discusses emerging preclinical and translational approaches; these should not be interpreted as established clinical therapies.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationCells
AuthorsKenta Mosallanejad, Cédric Hubeau, Annette Schwartz Sterman +1 more
InstitutionAbbVie (United States)
Study typeArticle
Indexed viaOpenAlex
Source typeResearch paper
PublishedAug 4, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Microbial metabolite hyodeoxycholic acid induces macrophage immunometabolic reprogramming and alleviates ulcerative colitis.
The work links a missing bacterial metabolite (HDCA) to macrophage metabolism and reduced intestinal inflammation in experimental models, highlighting a potential microbiome-derived pathway that could be targeted for...
A bile acid-GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis.
Fibrosis and stricturing are key problems in Crohn’s disease with limited therapies; this study identifies a microbiota–bile acid–GPBAR1 pathway by which a specific probiotic mix reduced inflammation and fibrosis in...
Microplastics Accumulation in Fibrotic Intestinal Tissue of Crohn's Disease Patients
Cure8 found this source from sciencedirect.com, but the page could not be read reliably yet. It is tagged for Crohn's disease, Inflammatory bowel disease, and Research and clinical trials. Open the original article for...